Compounds > haloperidol

haloperidol and losartan potassium

haloperidol has been researched along with losartan potassium in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's3 (60.00)29.6817
2010's2 (40.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ1
Becker, W; Béhé, M; Brines, M; Brück, W; Cerami, A; Degner, D; Ehrenreich, H; Falkai, P; Hasselblatt, M; Jacob, S; Knerlich, F; Maier, W; Meller, J; Rüther, E; Sirén, AL; von Ahsen, N; Woldt, H1
Mahadik, SP; Pillai, A1
Dhandapani, KM; Mahadik, SP; Pillai, A; Pillai, BA; Terry, AV1
Dias, R; Goetghebeur, PJ; Lerdrup, L; Sylvest, A1

Trials

1 trial(s) available for haloperidol and losartan potassium

ArticleYear
Erythropoietin: a candidate compound for neuroprotection in schizophrenia.
    Molecular psychiatry, 2004, Volume: 9, Issue:1

    Topics: Adult; Aged; Aged, 80 and over; Animals; Antipsychotic Agents; Cell Death; Cells, Cultured; Cognition; Erythropoietin; Female; Haloperidol; Humans; Indium Radioisotopes; Injections, Intraperitoneal; Male; Mice; Mice, Inbred BALB C; Neurons; Neuroprotective Agents; Rats; Recombinant Proteins; Schizophrenia, Paranoid; Tomography, Emission-Computed, Single-Photon

2004

Other Studies

4 other study(ies) available for haloperidol and losartan potassium

ArticleYear
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
    Toxicological sciences : an official journal of the Society of Toxicology, 2013, Volume: 136, Issue:1

    Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests

2013
Differential effects of haloperidol and olanzapine on the expression of erythropoietin and its receptor in rat hippocampus and striatum.
    Journal of neurochemistry, 2006, Volume: 98, Issue:5

    Topics: Animals; Antipsychotic Agents; Benzodiazepines; Blotting, Western; Corpus Striatum; Dose-Response Relationship, Drug; Endothelial Cells; Erythropoietin; Gene Expression; Glial Fibrillary Acidic Protein; Haloperidol; Hippocampus; Immunohistochemistry; Male; Olanzapine; Phosphopyruvate Hydratase; Rats; Receptors, Erythropoietin

2006
Erythropoietin prevents haloperidol treatment-induced neuronal apoptosis through regulation of BDNF.
    Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology, 2008, Volume: 33, Issue:8

    Topics: Animals; Antipsychotic Agents; Apoptosis; Apoptosis Regulatory Proteins; bcl-Associated Death Protein; Blotting, Western; Brain-Derived Neurotrophic Factor; Caspase 3; Cell Death; Cell Survival; Cells, Cultured; Cerebral Cortex; Erythropoietin; Gene Expression Regulation; Haloperidol; Immunohistochemistry; Male; Mice; Microtubule-Associated Proteins; Neurons; Rats; Rats, Sprague-Dawley; Recombinant Proteins

2008
Erythropoietin reverses the attentional set-shifting impairment in a rodent schizophrenia disease-like model.
    Psychopharmacology, 2010, Volume: 212, Issue:4

    Topics: Animals; Antipsychotic Agents; Attention; Behavior, Animal; Benzhydryl Compounds; Discrimination, Psychological; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Therapy, Combination; Epoetin Alfa; Erythropoietin; Executive Function; Haloperidol; Male; Modafinil; Neuropsychological Tests; Phencyclidine; Rats; Recombinant Proteins; Reward; Schizophrenia; Schizophrenic Psychology

2010